Investor Relations Press Releases March 27, 2023 Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease March 1, 2023 Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates February 27, 2023 Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference View all press releases » Events & Presentations Mar 6, 2023 at 9:50 AM EST Cowen 43rd Annual Health Care Conference Listen to Webcast Mar 1, 2023 at 8:30 AM EST Amicus Fourth Quarter and Full Year 2022 Results Conference Call and Webcast Listen to Webcast Feb 22 - Feb 26, 2023 19th Annual WORLDSymposium™ 2023 View all events & presentations »
March 27, 2023 Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease
Mar 1, 2023 at 8:30 AM EST Amicus Fourth Quarter and Full Year 2022 Results Conference Call and Webcast Listen to Webcast